바로가기메뉴

본문 바로가기 주메뉴 바로가기

Risk Factors for Primary Multidrug Resistant Tuberculosis

Tuberculosis & Respiratory Diseases / Tuberculosis & Respiratory Diseases,
2005, v.59 no.6, pp.600-605




  • Downloaded
  • Viewed

Abstract

Background : Primary multidrug-resistant tuberculosis is defined as Mycobacterium tuberculosis isolates that are resistant to at least isoniazid and rifampin in never-been-treated tuberculosis patients, and this malady is caused by the transmission of a resistant strain from one patient, who is infected with a resistant Mycobacterium tuberculosis strain, to another patient. The prevalence of primary multidrug-resistant tuberculosis could be a good indicator of the performance of tuberculosis control programs in recent years. We conducted a case-control study to identify the risk factors for primary multidrug-resistant tuberculosis. Methods : From January 1, 2001 to, June 30, 2003, by conducting prospective laboratory-based surveillance, we identified 29 hospitalized patients with P-MDRTB and these patients constituted a case group in this study. The controls were represented by all the patients with culture-confirmed drug susceptible tuberculosis who were admitted to National Masan Hospital during the same study period. The odds ratios for the patients with primary multidrug-resistant tuberculosis, as compared with those of the patients with drug susceptible tuberculosis, were calculated for each categorical variable with 95% confidence intervals. Results : Multivariate logistic regression showed that the presence of diabetes mellitus (odds ratio 2.68; 95% confidence interval, 1.05-6.86) was independently associated with having primary multidrug-resistant tuberculosis. Conclusion : This study has shown that diabetes mellitus might be one of the risk factors for primary multidrug-resistant tuberculosis. (Tuberc Respir Dis 2005; 59: 600-605)

keywords
Drug resistance, Mycobacterium tuberculosis, Risk factor, Drug resistance, Mycobacterium tuberculosis, Risk factor

Reference

1.

Espinal MA, (2000) Raviglione MC. Standard short-course chemotherapy for drug resistant tuberculosis treatment outcomes in 6 countries. ,

2.

Bashar M, (2001) Increased incidence of multidrug-resistant tuberculosis in diabetic patients on the Bellevue Chest Service,1987-1997,

3.

Mahmoudi A, Iseman MD. Pitfalls in the care of patients with tuberculosis common errors and their association with the acquisition of drug resistance. JAMA 1993,

4.

Kessler I, (1971) Mortality experience of diabetic patients:a twenty-six year follow-up study,

5.

CDC. , (.1999) Primary multidrug-resistant tuberculosis-Ivanovo Oblast,

6.

Rsch-Gerdes S, (1999) Epidemiology of resistant tuberculosis in Europe. ,

7.

In Murray J, (1988) Textbook of respiratory medicine,

8.

Espinal MA, (2001) Global trends in resistance to antituberculosis drugs. ,

9.

Sasaki A, Mortality and causes of death in Type 2 diabetic patients a long-term follow-up study in Osaka District,

10.

World Health Organization, (2000) . Anti-tuberculosis drug resistance in the world. Report no. 2 : Prevalence and trends,

11.

Reider HL, Snider DE Jr. Epidemiology of tuberculosis in the United States. Epidemiol Rev. Epidemio Rev 1989,

12.

Kim SJ, (1995) Incidence of pulmonary tuberculosis among diabetics. ,

13.

Koziel H, (1995) Pulmonary complications of diabetes mellitus. ,

Tuberculosis & Respiratory Diseases